{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:06:14Z","timestamp":1777050374265,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clgc.2025.102481","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:54:03Z","timestamp":1765299243000},"page":"102481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Indeterminate Surgical Margins (Rx) in Renal Cell Carcinoma Surgery: Rates, Predictive Factors, and Impact on Overall Survival"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-3948","authenticated-orcid":false,"given":"Dejan K.","family":"Filipas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 I.","family":"Nolazco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin V.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Beatrici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhieddine","family":"Labban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart R.","family":"Lipsitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit","family":"Fisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9201-3217","authenticated-orcid":false,"given":"Toni K.","family":"Choueiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-8529","authenticated-orcid":false,"given":"Alexander P.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quoc-Dien","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7038-5861","authenticated-orcid":false,"given":"Steve L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clgc.2025.102481_bib0001","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102481_bib0002","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.clgc.2025.102481_bib0003","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European Association of Urology Guidelines on renal cell Carcinoma: the 2022 update","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102481_bib0004","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/JU.0000000000001911","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102481_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JU.0000000000001912","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part II","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102481_bib0006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.urolonc.2022.09.014","article-title":"Nephrometry and cumulative morbidity after partial nephrectomy: a standardized assessment of complications in the context of PADUA and R.E.N.A.L. scores","volume":"41","author":"Filipas","year":"2023","journal-title":"Urol Oncol."},{"issue":"1","key":"10.1016\/j.clgc.2025.102481_bib0007","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.juro.2012.09.042","article-title":"\"Trifecta\" in partial nephrectomy","volume":"189","author":"Hung","year":"2013","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.clgc.2025.102481_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/cancers14071781","article-title":"Pentafecta for radical nephroureterectomy in patients with high-risk upper tract urothelial carcinoma: a proposal for standardization of quality care metrics","volume":"14","author":"K\u00f6nig","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.clgc.2025.102481_bib0009","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2009.03.048","article-title":"Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery","volume":"57","author":"Bensalah","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102481_bib0010","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.urology.2021.04.058","article-title":"Does a positive surgical margin after nephron sparing surgery affect oncological outcome in renal cell carcinoma? A systematic review and meta-analysis","volume":"156","author":"Hakam","year":"2021","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.clgc.2025.102481_bib0011","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ncpuro1121","article-title":"Importance of surgical margins in the management of renal cell carcinoma","volume":"5","author":"Lam","year":"2008","journal-title":"Nat Clin Pract Urol"},{"issue":"6 Pt 1","key":"10.1016\/j.clgc.2025.102481_bib0012","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.juro.2006.08.008","article-title":"Positive surgical parenchymal margin after laparoscopic partial nephrectomy for renal cell carcinoma: oncological outcomes","volume":"176","author":"Permpongkosol","year":"2006","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102481_bib0013","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.juro.2016.02.075","article-title":"Positive surgical margins increase risk of recurrence after partial nephrectomy for high risk renal tumors","volume":"196","author":"Shah","year":"2016","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102481_bib0014","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.juro.2008.01.100","article-title":"Positive surgical margins at partial nephrectomy: predictors and oncological outcomes","volume":"179","author":"Yossepowitch","year":"2008","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102481_bib0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.eururo.2011.11.028","article-title":"Positive surgical margins after nephron-sparing surgery","volume":"61","author":"Marszalek","year":"2012","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102481_bib0016","doi-asserted-by":"crossref","first-page":"e903","DOI":"10.1016\/j.clgc.2018.03.003","article-title":"Predictors of cancer-specific survival after disease recurrence in patients with renal cell carcinoma: the effect of time to recurrence","volume":"16","author":"Rieken","year":"2018","journal-title":"Clin Genitourin Cancer"},{"issue":"11","key":"10.1016\/j.clgc.2025.102481_bib0017","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1245\/s10434-022-12052-8","article-title":"Impact of renal cell carcinoma histological variants on recurrence after partial nephrectomy: a multi-institutional, prospective study (UROCCR Study 82)","volume":"29","author":"Tabourin","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102481_bib0018","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/bju.15415","article-title":"Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?","volume":"128","author":"Abu-Ghanem","year":"2021","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.clgc.2025.102481_bib0019","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1055\/s-0034-1391853","article-title":"Relationship between indeterminate or positive lateral margin and local recurrence after endoscopic resection of colorectal polyps","volume":"3","author":"Makazu","year":"2015","journal-title":"Endosc Int Open"},{"issue":"5","key":"10.1016\/j.clgc.2025.102481_bib0020","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.jtcvs.2019.09.075","article-title":"The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancer","volume":"159","author":"Raman","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9596","key":"10.1016\/j.clgc.2025.102481_bib0021","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clgc.2025.102481_bib0022","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102481_bib0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0344-0338(11)80700-4","article-title":"The pathologist and the residual tumor (R) classification","volume":"190","author":"Hermanek","year":"1994","journal-title":"Pathol Res Pract"},{"issue":"2","key":"10.1016\/j.clgc.2025.102481_bib0024","doi-asserted-by":"crossref","first-page":"233","DOI":"10.23736\/S2724-6051.20.03728-5","article-title":"Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer: analysis of the National Cancer Database","volume":"73","author":"Ryan","year":"2021","journal-title":"Minerva Urol Nephrol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102481_bib0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/JU.0000000000000591","article-title":"Impact of resection technique on perioperative outcomes and surgical margins after partial nephrectomy for localized renal masses: a prospective multicenter study","volume":"203","author":"Minervini","year":"2020","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.clgc.2025.102481_bib0026","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa2106391","article-title":"Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma","volume":"385","author":"Choueiri","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.clgc.2025.102481_bib0027","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.19.00107","article-title":"Predicting renal cancer recurrence: defining limitations of existing prognostic models with prospective trial-based validation","volume":"37","author":"Correa","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102481_bib0028","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/bju.15673","article-title":"Risk models for recurrence and survival after kidney cancer: a systematic review","volume":"130","author":"Usher-Smith","year":"2022","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.clgc.2025.102481_bib0029","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.juro.2007.03.045","article-title":"Positive margins in laparoscopic partial nephrectomy in 855 cases: a multi-institutional survey from the United States and Europe","volume":"178","author":"Breda","year":"2007","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.clgc.2025.102481_bib0030","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1470-2045(22)00487-9","article-title":"Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"23","author":"Powles","year":"2022","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102481_bib0031","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clgc.2012.09.010","article-title":"Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management","volume":"11","author":"Borghesi","year":"2013","journal-title":"Clin Genitourin Cancer"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:57:51Z","timestamp":1768921071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325001818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1558767325001818"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102481","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indeterminate Surgical Margins (Rx) in Renal Cell Carcinoma Surgery: Rates, Predictive Factors, and Impact on Overall Survival","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102481"}}